Dippel N, In-Albon T, Schneider S, Christiansen H, Brakemeier E-L
Philipps-University Marburg, Marburg, Germany.
University of Koblenz-Landau, Landau, Germany.
Pilot Feasibility Stud. 2022 Jul 11;8(1):145. doi: 10.1186/s40814-022-01091-3.
Depression is a serious disorder in childhood and adolescence. Affected children and adolescents show significant impairments in various aspects of life. Studies on the effectiveness or efficacy of psychotherapy in depressed children and adolescents are qualitatively very heterogeneous and reveal small effect sizes. There is thus a need to better tailor psychotherapy approaches to these age groups to improve outcomes like parent-child relationship, symptomatology, or quality of life. To address this gap, we designed a modular, individualized treatment program for children and adolescents based on the Cognitive Behavioral Analysis System of Psychotherapy (CBASP) including caregiver involvement.
This quasi-experimental pilot feasibility trial is a phase 1 to phase 2 study investigating the feasibility and effectiveness of CBASP@YoungAge by including an intervention group (CBASP@YoungAge) and a treatment-as-usual control group. The treatment of depressive symptoms as well as interpersonal problems with primary caregivers are the main targets of CBASP@YoungAge. Personalization is ensured concerning the treatment course, caregivers' involvement, and the patient's age. The primary outcome relates to two areas: the feasibility of the CBASP@YoungAge treatment program in an outpatient context and a change in patients' depressive symptomatology from before to after treatment. We conduct a brief process evaluation after each session in the intervention group to closely monitor the treatment process and examine feasibility from the therapists' and patients' perspectives and mechanisms of symptom change. In addition, we consider interpersonal behavior between children and caregivers, parenting behavior, and monitor the global-health-index in children and parents as secondary outcomes. Pre-, post-, and follow-up data are evaluated.
This is the first study of a modular-based intervention program for children and adolescents with depression and a clear focus on the interpersonal problems between the depressed young patient and her/his caregiver. It will provide important knowledge on the feasibility and effectiveness of the program and potential benefits of including caregivers in psychotherapy. Based on this study's results, we plan a multicenter, randomized, controlled trial whose long-term aim is to improve the psychotherapeutic care of young patients with depression while preventing persistent courses of depressive disorders.
German Clinical Trials Register, DRKS (identifier DRKS00023281 ). Registered 17 November 2020-Retrospectively registered.
抑郁症是儿童和青少年时期的一种严重疾病。受影响的儿童和青少年在生活的各个方面都表现出明显的损害。关于心理治疗对抑郁儿童和青少年有效性的研究在质量上差异很大,且效果量较小。因此,需要更好地为这些年龄组量身定制心理治疗方法,以改善诸如亲子关系、症状表现或生活质量等结果。为了填补这一空白,我们基于认知行为分析心理治疗系统(CBASP)为儿童和青少年设计了一个模块化的个性化治疗方案,包括照顾者的参与。
这项准实验性试点可行性试验是一项从1期到2期的研究,通过纳入一个干预组(CBASP@YoungAge)和一个常规治疗对照组来调查CBASP@YoungAge的可行性和有效性。治疗抑郁症状以及与主要照顾者的人际问题是CBASP@YoungAge的主要目标。在治疗过程、照顾者的参与以及患者年龄方面确保个性化。主要结果涉及两个方面:CBASP@YoungAge治疗方案在门诊环境中的可行性以及患者治疗前后抑郁症状的变化。我们在干预组的每次治疗后进行简短的过程评估,以密切监测治疗过程,并从治疗师和患者的角度检查可行性以及症状变化的机制。此外,我们将儿童与照顾者之间的人际行为、养育行为以及监测儿童和父母的总体健康指数作为次要结果。对治疗前、治疗后和随访数据进行评估。
这是第一项针对患有抑郁症的儿童和青少年的基于模块化的干预方案的研究,并且明确关注抑郁的年轻患者与其照顾者之间的人际问题。它将提供关于该方案的可行性和有效性以及在心理治疗中纳入照顾者的潜在益处的重要知识。基于这项研究的结果,我们计划开展一项多中心、随机、对照试验,其长期目标是改善对患有抑郁症的年轻患者的心理治疗护理,同时预防抑郁症的持续病程。
德国临床试验注册中心,DRKS(标识符DRKS00023281)。2020年11月17日注册——追溯注册。